Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novo Nordisk A/S Class B (NOVCb)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
106.40 +0.20    +0.19%
11:38:11 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DK0060534915 
WKN:  A1XA8R
  • Volume: 5,508
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 106.38 - 107.48
Novo Nordisk B 106.40 +0.20 +0.19%

NOVCb Recent Sentiments

 
This page contains information on users’ sentiments for the Novo Nordisk A/S Class B stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 30, 2022 Gionata Kissov   104.04 Jun 24, 2022 @ 105.78 +1.67%
May 03, 2022 Gionata Kissov   108.00 May 30, 2022 @ 100.04 -7.37%
Apr 21, 2022 hosam alhashlamoun   105.96 May 13, 2022 @ 102.16 -3.59%
Apr 08, 2022 Eelco Dullaart   111.40 Apr 29, 2022 @ 109.34 -1.85%
Apr 08, 2022 Cedric Carre   110.16 Apr 29, 2022 @ 109.34 -0.74%
Mar 31, 2022 Hermann wirsum   102.14 Apr 04, 2022 @ 103.36 +1.19%
Mar 16, 2022 Felix Gärtner   95.92 Apr 08, 2022 @ 111.52 +16.26%
Mar 09, 2022 Paul Zonderland   92.15 Mar 29, 2022 @ 99.23 +7.68%
Jan 27, 2022 Melanie Kaffka   86.04 Feb 18, 2022 @ 89.10 +3.56%
Jan 25, 2022 Kasper Hauser   83.86 Feb 18, 2022 @ 89.10 -6.25%
Jan 06, 2022 Matthias Cremer   89.83 Jan 28, 2022 @ 86.04 -4.22%
Jan 04, 2022 lucas LUCAS   92.40 Jan 10, 2022 @ 88.74 +3.96%
Jan 03, 2022 Roman Pawlowski   96.07 Jan 28, 2022 @ 86.04 -10.44%
Dec 28, 2021 Stefan Mm   98.00 Jan 21, 2022 @ 85.16 -13.10%
Dec 20, 2021 Thomas Werner   91.56 Jan 14, 2022 @ 84.49 -7.72%
Nov 25, 2021 Matthias Cremer   96.71 Dec 17, 2021 @ 102.42 +5.90%
Nov 18, 2021 Inna Veys   101.16 Dec 10, 2021 @ 100.86 -0.30%
Nov 02, 2021 Patrick Gnauck   94.50 Nov 26, 2021 @ 94.90 +0.42%
Oct 22, 2021 Matthias Cremer   90.32 Nov 12, 2021 @ 98.42 +8.97%
Oct 08, 2021 Dietmar Knoch   85.31 Oct 11, 2021 @ 85.42 +0.13%
Sep 01, 2021 Paolo Pallocca   84.11 Sep 24, 2021 @ 86.43 +2.76%
Aug 12, 2021 lucas LUCAS   85.76 Aug 16, 2021 @ 87.17 +1.64%
Aug 10, 2021 Patrik Biegel   85.66 Sep 03, 2021 @ 84.84 +0.96%
Jul 30, 2021 Andreas Bohn   76.82 Aug 20, 2021 @ 91.83 +19.54%
Jul 02, 2021 Eelco Dullaart   71.47 Jul 23, 2021 @ 76.82 +7.49%
Jun 04, 2021 Iñi Grs   65.83 Jun 25, 2021 @ 68.61 +4.22%
Jun 02, 2021 massimo piazzalunga   64.92 Jun 25, 2021 @ 68.61 +5.68%
May 14, 2021 Andreas Bohn   65.18 Jun 04, 2021 @ 66.00 +1.26%
Apr 09, 2021 JiiVee   58.75 Apr 12, 2021 @ 58.86 +0.19%
Apr 08, 2021 Andreas Bohn   58.20 Apr 30, 2021 @ 61.25 +5.24%
Mar 30, 2021 Jan Schäfer   58.06 Apr 23, 2021 @ 61.00 +5.06%
Mar 08, 2021 Julian Fir   57.78 Apr 02, 2021 @ 57.60 -0.31%
Feb 11, 2021 Sotiris Seimanidis   59.82 Mar 05, 2021 @ 57.39 -4.06%
Feb 03, 2021 Andreas Bohn   61.20 Feb 26, 2021 @ 58.76 -3.99%
Jan 28, 2021 Stefan Hennigs   58.25 Feb 19, 2021 @ 61.08 +4.86%
Jan 28, 2021 Tobias Hammerl   58.03 Feb 19, 2021 @ 61.08 +5.26%
Jan 15, 2021 Matthias Cremer   59.75 Jan 15, 2021 @ 59.75 0.00%
Jan 08, 2021 Eli Barrientos...   57.10 Jan 29, 2021 @ 57.02 -0.14%
Dec 30, 2020 Cornelius Lutz   57.95 Jan 22, 2021 @ 59.60 +2.85%
Sep 15, 2020 Benji Mufasa   57.00 Oct 09, 2020 @ 61.00 +7.02%
Aug 14, 2020 Jan Nwsl   55.70 Sep 04, 2020 @ 54.64 -1.90%
Aug 06, 2020 Frank Farina   54.17 Aug 28, 2020 @ 55.28 +2.05%
Aug 05, 2020 Bernd Brand   54.99 Aug 28, 2020 @ 55.28 +0.53%
Jul 14, 2020 Andreas Bohn   57.08 Aug 07, 2020 @ 55.11 -3.45%
Jun 24, 2020 Alb Gra   59.58 Jul 17, 2020 @ 58.65 -1.56%
Jun 15, 2020 Matthias Gutbrod   57.98 Jul 10, 2020 @ 57.80 -0.31%
Jun 02, 2020 Alberto Gómez Sánchez   58.41 Jun 26, 2020 @ 59.11 +1.20%
May 21, 2020 René Ga   59.43 Jun 12, 2020 @ 58.05 -2.32%
May 18, 2020 Josef Wegerer   59.30 Jun 12, 2020 @ 58.05 -2.11%
May 12, 2020 Sigrid Piotrowski   57.93 Jun 05, 2020 @ 57.30 -1.09%
More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NOVOb Comments

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Toby Brunt
Toby Brunt Apr 19, 2022 5:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Does anyone no of a particular reason that NOVO B is going so far down today? Is it profit taking before Q1 2022 results?
Reply
0 0
Report
Sandy SS
Sandy SS Feb 09, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New Target 825 by EOM
Reply
1 0
Report
Sandy SS
Sandy SS Feb 09, 2022 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New Target 825
Reply
0 0
Report
Terrible Investor
TerribleInvestor Nov 25, 2021 5:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Consolidating nicely for leg up to 850!🌟
Reply
1 0
Report
Ralf Adams
Ralf Adams Feb 11, 2021 4:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Results from clinical study just published in New England Journal of Medicine: Impressive new weight loss results for Semaglutide at only 2.4 mg once a week. Drug mimics the gut hormone glucagon-like peptide-1 (GLP-1) that is secreted by your gut after eating.
Reply
0 1
Report
Candy Man
Candy Man Jan 14, 2021 4:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now is the time to buy - novo is very seasonal stock goes up the most in jan/feb.
Reply
1 0
Report
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bullish??
Reply
2 0
Report
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No. Funds are selling. Time to wait to go long...
Reply
0 0
Report
White Wizard
White Wizard May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Perfect opportunity to make short,,
Reply
0 1
Report
Wassim Khayata
Wassim Khayata May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can you explain why please?
Reply
2 0
Report
Jeff Heimann
Jeff Heimann May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No explaning? 🤷
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
because he has no explanation. Novo nordisk is a soli long-term stock. I know a lot about opioid treatments, and methadon is changing to lipo-methadon, wich has really only one competitor on the global field. That competitor is Camurus AB with their product buvidol. I tecommend to all investors to buy and HOLD for these two companies, because there is no other options for a opioid-replacement-care, except Suboxone, and that is going to be replaced Lipo-methadon or Buvidol, at least here in Finland. Suboxone is manufactured for Indivor Inc, by Aquestive Therapeutics, if someone wants to do a little research.
Reply
2 0
Report
Hairol Azhar Abdul Kadir
Hairol Azhar Abdul Kadir Jan 19, 2020 2:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bullish sentiment.
Reply
0 0
Report
Petar Petrov
Petar Petrov Jul 15, 2019 2:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why is going so low???
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email